Couple alleges clinic used the wrong sperm in IVF, prompting lawsuit
JACKSONVILLE, Fla. — A Jacksonville couple has filed suit against a local fertility clinic after a DNA test confirmed the husband is not the biological father of their daughter, according to a local news report. Natalie and Joshua Strong said they became alarmed when a routine blood test after their daughter’s birth revealed the child was B-positive while both parents are blood-type negative. A subsequent DNA test confirmed Joshua is not the biological father.
What the Strongs say happened
According to reporting on the case, the couple underwent two rounds of in vitro fertilization (IVF) at Brown Fertility Associates in Jacksonville. The Strongs allege negligence by the clinic, saying staff used sperm from an unidentified man to create their embryo. Their attorney, Robert Marcereau, told reporters that such mix-ups are not isolated and pointed to understaffing and corner-cutting in the fertility industry as drivers behind these errors.
In the couple’s words: “It took away the euphoria of having a baby,” Natalie said, while Joshua added, “I honestly don’t know how to answer it,” and described the emotional toll: “This is going to affect us for the rest of our lives.” The family is seeking $50,000 in damages and wants the clinic to account for the husband’s sperm and to disclose any genetic information necessary for the child’s health.
(Source: local reporting on the case — see WSVN.)
How often do errors like this occur?
Errors in assisted reproductive technology (ART) are rare compared with the total number of IVF cycles, but even infrequent mistakes can have profound consequences for families. National reporting and practitioner groups have documented isolated cases of specimen mix-ups, mislabeling, or incorrect embryo transfers. Reliable national tracking of clinical errors specifically tied to chain-of-custody failures is limited, and many clinics report outcomes through voluntary registries and required reporting for certain metrics.
For broad data on IVF use and outcomes in the United States, the Centers for Disease Control and Prevention (CDC) publishes annual reports on ART cycles and outcomes, which provide context for how many procedures are performed and the scale at which clinics operate: CDC — Assisted Reproductive Technology (ART) Reports.
Regulation, oversight, and professional guidance
In the U.S., oversight of fertility clinics is a mix of federal, state, and professional oversight. The Food and Drug Administration (FDA) regulates certain aspects of gamete and tissue safety (for example, screening of donors for communicable diseases), but many operational procedures inside fertility clinics—such as chain-of-custody practices, staffing levels, and internal laboratory controls—are governed primarily by professional standards and state laws rather than a single federal regulator.
The American Society for Reproductive Medicine (ASRM) provides recommendations and best-practice guidance intended to minimize risks, including strict specimen identification procedures, double-checks during critical handling steps, and staff training protocols. Patients and advocates often point to these guidelines when calling for stricter oversight or enforcement: ASRM — Practice Guidelines and Ethics.
Legal and emotional consequences for families
Families affected by clinic errors may pursue civil claims including negligence, breach of contract, and emotional distress. Remedies vary by jurisdiction and the facts of each case. Beyond financial compensation, many families seek transparency about what happened, confirmation that the error is contained (for example, whether sperm or embryos may have been used elsewhere), and access to genetic information critical for a child’s medical care.
Beyond legal pursuits, affected parents and children face complex emotional and identity issues, including grief, anger, and questions about parentage and medical history. Medical professionals and counselors familiar with reproductive medicine emphasize the importance of genetic information for diagnosing and treating medical conditions and for informed family planning.
What patients should ask and expect from fertility clinics
- Ask about the clinic’s chain-of-custody procedures and how samples are labeled and tracked.
- Request information on staff training, staffing ratios, and whether critical steps require independent verification (two-person checks).
- Ask how the clinic documents consent and how it notifies patients of any adverse events or errors.
- Seek clarity on whether the clinic participates in external quality assessments, laboratory accreditation, or voluntary reporting programs.
Patients may also consider seeking independent legal and genetic counseling if irregularities are suspected.
Broader implications and next steps
The Jacksonville suit underscores broader questions about risk management in fertility medicine: how clinics prevent human error, how transparent they must be when mistakes occur, and whether current oversight systems sufficiently protect patients. Advocates call for clearer reporting requirements, stronger enforcement of best practices, and easier access to genetic information when errors are suspected.
Resources
- CDC — Assisted Reproductive Technology (ART) Reports: https://www.cdc.gov/art/
- ASRM — Practice Guidelines and Ethics: https://www.asrm.org
- FDA — Regulation of Human Cells, Tissues, and Cellular and Tissue-Based Products (for background on federal oversight of donor screening and tissue safety): https://www.fda.gov
- Local reporting referenced in this article: WSVN local news coverage: https://wsvn.com
Disclaimer: This article summarizes a local news report about a pending lawsuit and provides general background on fertility clinic practices and oversight. Readers with legal or medical questions should consult an attorney or qualified reproductive medicine specialist.
